【结 构 式】 |
【分子编号】19698 【品名】(2S)-2-(2-methoxyphenyl)propionic acid 【CA登记号】 |
【 分 子 式 】C10H12O3 【 分 子 量 】180.20348 【元素组成】C 66.65% H 6.71% O 26.64% |
合成路线1
该中间体在本合成路线中的序号:(II)The condensation of racemic (3aRS,4RS,6SR,7aSR)-6-(hydroxymethyl)-4-(2-methoxyphenyl)perhydroisoindol-4-ol (I) with 2(S)-(2-methoxyphenyl)propionic acid (II) by means of hydroxybenzotriazole and 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide in dichloromethane gives the diastereomeric amide (III), which is tosylated with tosyl chloride and submitted to chromatography yielding the (3aS,4S,6R,7aR)(S)-enantiomer (IV) as an optically pure isomer. Finally, this compound is allowed to react with potassium cyanide in hot DMSO affording RPR-111905. The starting compounds, the perhydroisoindole (I) and the propionic acid (II) have been obtained as follows: a) The cyclization of 5-(acetoxymethyl)-2-cyclohexen-1-one (V) with N-(butoxymethyl)-N-(trimethylsilylmethyl)benzylamine (VI) by means of trifluoroacetic acid (TFA) in dichloromethane gives racemic (3aRS,6SR,7aSR)-6-(acetoxymethyl)-2-benzylperhydroisoinol-4-one (VII), which is submitted to a Grignard condensation with 2-methoxyphenylmagnesium bromide (VIII) in THF yielding the racemic (3aRS,4RS,6SR,7aSR)(IX). Finally, this compound is debenzylated by hydrogenation with H2 over Pd/C in hot ethanol affording the desired racemic diol (I). b) The condensation of 2-(2-methoxyphenyl)acetic acid (X) with (4S,5S)-4-methyl-5-phenyloxazolidin-2-one (XI) by means of NaH, pivaloyl chloride and butyllithium gives the acylated oxazolidinone (XII), which is methylated regioselectively with sodium hexamethyldisylazane (Na-HMDS) and methyl iodide in THF yielding the 2(S)-methyl derivative (XIII). Finally, the hydrolysis of the oxazolidinone group of (XIII) with LiOH in THF-water affords the desired 2(S)-(2-methoxyphenyl)propionic acid (II).
【1】 Mutti, S.; et al.; Practical enantiospecific synthesis of RPR 111905: A novel non-peptide substance P antagonist. Tetrahedron Lett 1996, 37, 48, 8743. |
【2】 Achard, D.; Peyronel, J.-F.; Tabart, M. (Aventis Pharma SA); Perhydroisoindole derivs. as antagonists of substance P. FR 2727411; JP 1998509970; US 5739351; WO 9616939 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 19697 | (3aS,4R,6R,7aR)-6-(hydroxymethyl)-4-(2-methoxyphenyl)octahydro-1H-isoindol-4-ol | C16H23NO3 | 详情 | 详情 | |
(II) | 19698 | (2S)-2-(2-methoxyphenyl)propionic acid | C10H12O3 | 详情 | 详情 | |
(III) | 19699 | (2S)-1-[(4S,6R)-4-hydroxy-6-(hydroxymethyl)-4-(2-methoxyphenyl)octahydro-2H-isoindol-2-yl]-2-(2-methoxyphenyl)-1-propanone | C26H33NO5 | 详情 | 详情 | |
(IV) | 19700 | [(3aR,5R,7R,7aS)-7-hydroxy-7-(2-methoxyphenyl)-2-[(2S)-2-(2-methoxyphenyl)propanoyl]octahydro-1H-isoindol-5-yl]methyl 4-methylbenzenesulfonate | C33H39NO7S | 详情 | 详情 | |
(V) | 19701 | [(1R)-5-oxo-3-cyclohexen-1-yl]methyl acetate | C9H12O3 | 详情 | 详情 | |
(VI) | 19702 | N-benzyl-N-(butoxymethyl)-N-[(trimethylsilyl)methyl]amine; N-(butoxymethyl)(phenyl)-N-[(trimethylsilyl)methyl]methanamine | C16H29NOSi | 详情 | 详情 | |
(VII) | 19703 | [(3aR,5R,7aS)-2-benzyl-7-oxooctahydro-1H-isoindol-5-yl]methyl acetate | C18H23NO3 | 详情 | 详情 | |
(VIII) | 19704 | bromo(2-methoxyphenyl)magnesium | C7H7BrMgO | 详情 | 详情 | |
(IX) | 19705 | (3aS,4R,6R,7aR)-2-benzyl-6-(hydroxymethyl)-4-(2-methoxyphenyl)octahydro-1H-isoindol-4-ol | C23H29NO3 | 详情 | 详情 | |
(X) | 19706 | 2-(2-methoxyphenyl)acetic acid | 93-25-4 | C9H10O3 | 详情 | 详情 |
(XI) | 19707 | (4S,5S)-4-methyl-5-phenyl-1,3-oxazolidin-2-one | 17097-67-5 | C10H11NO2 | 详情 | 详情 |
(XII) | 19708 | (4S,5S)-3-[2-(2-methoxyphenyl)acetyl]-4-methyl-5-phenyl-1,3-oxazolidin-2-one | C19H19NO4 | 详情 | 详情 | |
(XIII) | 19709 | (4S,5S)-3-[(2S)-2-(2-methoxyphenyl)propanoyl]-4-methyl-5-phenyl-1,3-oxazolidin-2-one | C20H21NO4 | 详情 | 详情 |